2021: Pre-IPO funding in numbers

December 2021: 4.6mDKK Pre-IPO funding for life-science company DK life-science company [name undisclosed] with unique platform technology closes a pre-IPO round, as a last step prior to an anticipated IPO in 2022. Gemstone acts as the Company’s financial advisor, and facilitated the process and transaction. June 2021: 10.2mDKK pre-IPO convertible loan for Brain+ Brain+ closes…

Brain+ lands partnership with Roche

Copenhagen, December 2021 Brain+ lands partnership with Roche for entry in Germany 2 years ahead of plan. “Brain+ has signed a partnership agreement with RoX Health (https://roxhealth.com/), a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.” Read more about the partnership HERE.   Brain+…

Expres2ion Biotechnologies announces positive results for its breast cancer vaccine

Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its capsid virus-like particle (cVLP) breast cancer vaccine candidate ES2B-C001 demonstrated strong tumor-growth inhibiting effect in a mice model, thus reaching an important pre-clinical milestone ahead of schedule.” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO…

Sound Dimension subscribed 101%

Copenhagen, September 2021 The sound technology company Sound Dimensions’ new issue of units prior to the listing on Spotlight was subscribed for at around SEK 15.1 million, corresponding to a subscription rate of approximately 101 percent. Read the press release HERE. Sound Dimension was Gemstone Capital’s 11th IPO (2021)

EG acquires Aver Lauritzen

Copenhagen, August 17 2021 EG has acquired the Danish software company Aver & Lauritzen ApS and adds another practitioner system to the portfolio. EG is expanding its position as a specialised software supplier for the primary healthcare sector, especially for practitioners and specialists. Read more about the acquisition HERE. Gemstone Capital acted as buy side advisors